Walleye Capital’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-62,500
Closed -$256K 6121
2024
Q1
$256K Sell
62,500
-102,887
-62% -$460K ﹤0.01% 3794
2023
Q4
$968K Sell
165,387
-66,483
-29% -$350K ﹤0.01% 2372
2023
Q3
$1.19M Buy
231,870
+51,975
+29% +$244K ﹤0.01% 2130
2023
Q2
$865K Buy
+179,895
New +$622K ﹤0.01% 1972

Other funds holding AUGX

Walleye Capital's AUGX Position: Q2 2024 in Review

Walleye Capital sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 62,500 shares — an estimated $256K sold.

Walleye Capital first reported a position in AUGX in Q2 2023 and held it in 4 quarters. The position peaked at $1.19M in Q3 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Walleye Capital reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Walleye Capital sold 62,500 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $256K.
  • Walleye Capital first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Walleye Capital's Augmedix, Inc. Common Stock position peaked at $1.19M in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.